Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Endotoxicity This test checks for endotoxins (bacterial remnants that can cause health issues) in pharmaceutical products, ensuring they are free from contamination
Collagen Synthesis and Plumpness One of the most significant benefits of Vitamin C is its role in collagen synthesis
B12 Injections B12 injections can deliver targeted support to boost energy, enhance metabolism, improve mental clarity, strengthen the immune system, and promote overall wellness, helping you feel revitalized, focused, and at your best
5 New Product Launches and Innovations The market for GLP-1 receptor agonists is also expanding due to continuous innovation in drug formulations and delivery methods